Main description:

Pulmonary Pharmacology, Volume 98 provides in-depth reviews on the latest progresses about respiratory medicine research. Topics covered in this volume include an Update on Asthma Pathogenesis and New Therapeutic Targets, Progress in the Novel Therapeutic Targets for the Treatment of COPD, Update on Pulmonary Fibrosis Pathogenesis, Bronchodilators in Lung Diseases: from Potential Therapeutic Approaches to Current Challenges, Mechanisms of Action of Corticosteroids in Lung Diseases, Monoclonal Antibodies for the Treatment of Asthma: An Update, Asthma and COPD Exacerbation and Therapeutic Strategies, and more.

Other chapters cover Phosphodiesterase Inhibitors and Lung Diseases, Specialized Pro-Resolving Mediators in Lung Diseases, Anti-Fibrotic Strategies and Pulmonary Fibrosis, Renin Angiotensin System and Lung Diseases, Senotherapy for Lung Disease, Progress in the Development of Kinase Inhibitors for Treating Asthma and COPD, Prospects for Non-Antimicrobial Macrolides in Asthma and COPD, Delivery Technology of Inhaled Therapy for Asthma and COPD, and more.

Contents:

Preface W.S. FRED WONG 1. Update on Asthma Pathogenesis and New Therapeutic Targets Ian Adcock 2. Progress in the Novel Therapeutic Targets for the Treatment of COPD Judith C.W. Mak 3. Update on Pulmonary Fibrosis Pathogenesis Cecilia Prele 4. Bronchodilators in Lung Diseases: from Potential Therapeutic Approaches to Current Challenges Yassine Amrani 5. Mechanisms of Action of Corticosteroids in Lung Diseases Thai Tran 6. Monoclonal Antibodies for the Treatment of Asthma: An Update Garry M. Walsh 7. Asthma and COPD Exacerbation and Therapeutic Strategies Sebastian L. Johnston 8. Phosphodiesterase Inhibitors and Lung Diseases Clive Page 9. Specialized Pro-Resolving Mediators in Lung Diseases Bruce D. Levy 10. Anti-Fibrotic Strategies and Pulmonary Fibrosis Alastair Stewart 11. Renin Angiotensin System and Lung Diseases W.S. FRED WONG 12. Senotherapy for Lung Disease Peter J. Barnes 13. Progress in the Development of Kinase Inhibitors for Treating Asthma and COPD Paul Shapiro 14. Prospects for Non-Antimicrobial Macrolides in Asthma and COPD Michael J. Parnham 15. Delivery Technology of Inhaled Therapy for Asthma and COPD Ka Wing Jenny Lam